Developed by researchers at the Butantan Institute (Brazil) and Boston Children’s Hospital, part of the Harvard Medical School (USA), the innovation is capable of providing protection against all serotypes of the bacterium Streptococcus pneumoniae. FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO A novel vaccine against pneumonia that is less expensive and more...
